Child with suspected Obesity and Metabolic Syndrome

Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an…

Read More

Infant with Ambiguous Genitalia

Referral Guidelines are peer reviewed guidelines developed to assist referring providers in their approach to a patient presenting with common signs or symptoms suggestive of an…

Read More

Announcing the PES 2021 Virtual Annual Meeting

PES Going Virtual for 2021 We are pleased to announce the dates for the PES 2021 VIRTUAL Annual Meeting! April 30th- May 3rd, 2021 We are…

Read More

New Meds and Tech: Burosumab Twza (Crysvita – Ultragenyx Pharmaceuticals)

Prepared by Bhuvana Sunil, MD and Ambika Ashraf, MD Burosumab twza (Crysvita – Ultragenyx pharmaceuticals) is an injectable recombinant IgG1 human monoclonal antibody preparation neutralizing fibroblast…

Read More

New Meds and Tech: Semglee

Prepared by Christine Yu and Amit Lahoti Semglee™ is a new biosimilar insulin with an identical amino-acid sequence to insulin glargine. Semglee™, co-developed by Mylan Inc.…

Read More

New Meds and Tech: Freestyle Libre 2

Prepared by: Seth Marks and Amit Lahoti Updated July 22, 2020 The FreeStyle Libre 2 is the second generation of Abbott Laboratories’ flash glucose monitoring system.…

Read More

COVID-19 Resources

These resources have been identified by members as being useful during these difficult times. They are provided as a reference only. Timely information about COVID-19 that…

Read More

COVID-19 Resources Related to Endocrinology and Diabetes

Read More

New Meds and Tech: Riomet ER™

Riomet ER™ (metformin hydrochloride for extended-release oral suspension) was approved by the U.S. Food and Drug Administration (USFDA) on August 29, 2019 and became available in…

Read More

Child with Suspected Rickets

Primary Care provider guidelines for referral.

Read More